You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

large NSCLC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SBRT, NSCLC, Non-metastatic Trial in United States (GC4711, Placebo)

Recruiting
  • SBRT
  • +2 more
  • Gilbert, Arizona
  • +11 more
Aug 9, 2022

Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)

Not yet recruiting
  • Local Advanced Non-small Cell Lung Cancer
  • (no location specified)
Jun 2, 2023

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

NSCLC Stage III Trial in Paris, Milan, Barcelona (durvalumab plus platinum-based chemo (cisplatin or carboplatin plus

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed)
  • +2 more
  • Paris, France
  • +2 more
May 30, 2022

NSCLC (NSCLC) Trial in Canada, Japan, United States (iSABR, 25 Gray in 1 fraction for small peripheral tumors, iSABR, 50 Gray in

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • iSABR, 25 Gray in 1 fraction for small peripheral tumors
  • +5 more
  • Stanford, California
  • +3 more
Jul 27, 2022

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)

Recruiting
  • Ovarian Cancer, Epithelial
  • +14 more
  • Sutton, Surrey, United Kingdom
  • +6 more
Jul 22, 2022

Lung Tumors, Squamous Cell Lung Cancer, Adenocarcinoma of the Lung Trial in Guangzhou (Icotinib)

Recruiting
  • Lung Neoplasms
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 29, 2021

Carcinoma,Non-Small-Cell Lung, Metastatic Lung Cancer, Nonsmall Cell Lung Cancer Trial in Germany (Radiotherapy, Nivolumab)

Completed
  • Carcinoma，Non-Small-Cell Lung
  • +4 more
  • Berlin, Germany
  • +15 more
Jan 12, 2021

Locally Advanced NSCLC, Chemoradiotherapy, Cavitation Lung Trial (Upfront resection)

Not yet recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • +5 more
  • Upfront resection
  • (no location specified)
Nov 9, 2022

Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and

Completed
  • Cervical Cancer
  • +16 more
  • INCAGN02385
  • Los Angeles, California
  • +3 more
Oct 28, 2020

Immunotherapy in Locally Advanced or Oligometastatic NSCLC

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • induction therapy
  • Esslingen, Germany
    Klinikum Esslingen
Aug 15, 2022

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer Trial in United States (dietary

Completed
  • Adenocarcinoma of the Lung
  • +7 more
  • soy isoflavones
  • +4 more
  • Bay City, Michigan
  • +4 more
Nov 19, 2020

Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC

Recruiting
  • Non-Small Cell Lung Cancer
  • Neoadjuvant immunochemotherapy
  • Neoadjuvant chemotherapy
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Aug 1, 2023

Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

Recruiting
  • NSCLC
  • +6 more
  • Oral MRT-2359
  • Scottsdale, Arizona
  • +7 more
Dec 20, 2022

Advanced Non Small Cell Lung Cancer Trial run by the National Cancer Institute (NCI) (aerosolized aztreonam, aerosolized

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • aerosolized aztreonam
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Mar 28, 2023

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In

Recruiting
  • Lung Cancer
  • +2 more
  • Standard of care immune checkpoint inhbitors
  • Fairway, Kansas
  • +1 more
Sep 19, 2022

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

PLAsma Genomic Testing in Advanced Non-Small Cell Lung Cancer:

Not yet recruiting
  • Non-small Cell Lung Cancer
  • ctDNA liquid biopsy - Roche Avenio Assay
  • (no location specified)
Sep 14, 2022

NSCLC Trial in Hangzhou (sintilimab, pemetrexed, Carboplatin)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • sintilimab
  • +3 more
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Jul 11, 2022

Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

Recruiting
  • Metastatic Non-small Cell Lung Cancer (NSCLC)
  • +5 more
  • data collection
  • Oldenburg, Germany
    Pius-Hospital
Jul 20, 2022

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    NSCLC Trial (SABR, SoC systemic therapy)

    Recruiting
    • NSCLC
    • SABR
    • SoC systemic therapy
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Nov 7, 2022

    Lung Cancer Trial in Germany, Serbia, Switzerland (drug, radiation, procedure)

    Active, not recruiting
    • Lung Cancer
    • Löwenstein, Germany
    • +24 more
    Jan 9, 2023

    Resectable Early-stage Non-small Cell Lung Cancer

    Completed
    • Non-small Cell Lung Cancer
      • Alexandria, Egypt
      • +3 more
      Nov 21, 2022